Cardio Diagnostics Holdings Inc. Common stock

CDIONASDAQ • USD
ThemeGenomics & Precision Med.›Precision Medicine Platforms
1.72 USD
↗ 0.03 (1.78%)AT CLOSE (11:59 AM EDT)
1.75
↗ 0.03 (1.92%)
POST MARKET (AS OF 07:43 PM EDT)
Post Market
AS OF 07:43 PM EDT
1.75
↗ 0.03 (1.92%)
🔴Market: CLOSED

CDIO is currently priced at $1.72. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation metrics place CDIO at a fair price relative to peers.

Technical & fundamental data as of Jul 17, 2026.

Open?$1.65
High?$1.74
Low?$1.65
Prev. Close?$1.69
Volume?14.9K
Avg. Volume?36.8K
VWAP?$1.71
Rel. Volume?0.40x
Bid / Ask
Bid?$1.71 × 1.5K
Ask?$1.80 × 100
Spread?$0.09
Midpoint?$1.76
Valuation & Ratios
Market Cap?5.1M
Shares Out?3.0M
Float?2.7M
Float %?91.0%
P/E Ratio?N/A
P/B Ratio?0.57
EPS?-$2.25
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases and associated comorbidities by leveraging its Artificial Intelligence (AI)-driven Multi-Omics Engine. The company has developed two clinical products: Epi+Gen CHD and PrecisionCHD, epigenetics-based clinical blood tests capable of assessing risk for a coronary heart disease (CHD) event, including heart attacks. Additionally, its portfolio includes HeartRisk, a cardiovascular disease risk intelligence platform, and CardioInnovate360, a research-use-only solution launched to support the discovery, development, and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases.
Themes
Healthcare - Genomics & Precision Medicine›Precision Medicine PlatformsAI & Machine Learning›AI-Powered Analytics & Decision SystemsMedical Devices & HealthTech›Diagnostic Imaging & Equipment
Employees
17
Market Cap
5.0M
Industry
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Website
www.cdio.ai
Listed
2022-10-26
Address
311 W. SUPERIOR STREET
CHICAGO, IL 60645
Phone: 855-226-9991
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
0
Momentum?
50
Short Sent.?
80
Piotroski F-Score?2/9Weak
Altman Z-Score?-1.27Distress
Confidence?46%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?0.75%Low
Short Interest?20.2K
Days to Cover?1.0
Free Float2.7M
Avg Daily Volume40.6K
Settlement Date2026-06-30
Financial Health
Current Ratio?15.76Strong
Quick Ratio?15.76Strong
Cash Ratio?14.40Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.57CHEAP▾
P/S?
Peers
100
S&P
3
307.29HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
100
S&P
97
0.3CHEAP▾
EV/Sales?
S&P
97
-119.94CHEAP▾
Returns & Efficiency
ROE?
S&P
3
-74.7%WEAK▾
ROA?
S&P
3
-69.6%WEAK▾
Cash Flow & Enterprise
FCF?$-6072234
Enterprise Value?$-1986734
Fundamentals ratios updated end of day
MarketsMoversWatchlist